Wang et al. [19] have reported that the presence of XRCC1 rs25489 had a significant impact on primary tumor efficacy at the end of radiotherapy and may act as a biomarker for the curative effect of radiotherapy. The gene discussed is XRCC1; the disease is neoplasm.